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Abstract.  Fibroblast growth factor (FGF) has been 
shown to inhibit the differentiation of myogenic and 
adipogenic cell lines without inducing a proliferative 
response.  We have previously shown that agents capa- 
ble of activating protein kinase C  (PKC),  such as FGF 
and the phorbol ester tetradecanoyl phorbol-13-acetate 
(TPA), inhibit the differentiation of the adipogenic cell 
line TA1, as measured by the rapid loss of adipocyte- 
specific RNAs. We report here that the treatment of 
fully differentiated TA1  adipocytes with FGF at  10 
ng/ml  induces the reversal of adipocyte differentiation, 
even in cells where PKC activity has been down- 
regulated by TPA pretreatment.  In contrast,  TPA or 
lower concentrations of FGF (1  ng/ml),  both effective 
inducers of c-fos RNA in adipocytes, fail  to reverse 
adipocyte differentiation.  The adipocytes, however, will 
extinguish differentiation-specific functions in response 
to TPA by the addition of a calcium ionophore.  There- 
fore, we propose that there are two FGF-sensitive 
pathways in TA1  cells:  one responsible for the initia- 
tion of differentiation  (TPA sensitive) and another re- 
quired for maintenance  of the adipose phenotype (TPA 
insensitive).  These results suggest that activation of 
two distinct signaling  pathways-one PKC and calcium 
dependent, the other FGF activated but PKC indepen- 
dent- are capable of inhibiting  the biochemical events 
responsible for the maintenance  of adipocyte differenti- 
ation. 
I 
x has become increasingly  evident that the family of pep- 
tide hormones referred to as growth factors are locally 
acting intercellular  messengers whose effects are not al- 
ways related  to stimulation  of cell proliferation  (Sporn and 
Roberts, 1988). The signal transduction  pathways activated 
by interaction of these hormones with their cognate receptors 
remain  poorly defined despite the realization  that (at least) 
some of the receptors (e.g., for EGF and PDGF) harbor in- 
trinsic  tyrosine-specific protein  kinase activity (Ullrich and 
Yarden,  1988). Activation of a phosphatidylinositoi-specific 
phospholipase C  (PLC)  1 has also been proposed as a pri- 
mary event in signal transduction  in response to several of 
these growth factors (Berridge,  1987). Indeed, the activation 
of protein kinase  C  (PKC)  and the release of intracellular 
Ca  2÷ by the products of PLC action,  diacylglycerol  and ino- 
sitol  trisphosphate,  respectively,  have  been  implicated  as 
intracellular  events  mediating  the  growth  factor  response 
(Hirasawa  and  Nishizuka,  1985). 
A  useful experimental  paradigm  in  which proliferation- 
independent  actions of growth factors can be investigated is 
their ability to inhibit the differentiation  of determined stem 
cells. For example, EGF, fibroblast growth factor (FGF), and 
transforming  growth factor/3 (TGF-/3) have all been found to 
prevent  conversion  of  myoblasts  to  myocytes  without 
1. Abbreviations used in thispaper:  FGE fibroblast growth factor; LPL, li- 
poprotein  lipase;  PKC, protein  kinase C;  PLC,  phospholipase  C;  TPA, 
tetradecanoyl phorbol-13-acetate; TNE tumor necrosis factor. 
stimulating  cell  division  (Florini  et  al.,  1986;  Gospoda- 
rowicz et al.,  1976; Linkhart  et al.,  1981; Massagu6 et al., 
1986;  Miller et al.,  1988;  Spizz  et al.,  1986;  Wang and 
Rubenstein,  1988).  Particularly  intriguing  are  studies  of 
Lathrop etal. (1985a,b) documenting that FGF is also capa- 
ble of reversing the myogenic conversion  of BC3H1 cells as 
determined by the loss of expression of muscle-specific  pro- 
teins and/or RNAs. 
Analogous results with adipogenic cells lines indicate that 
growth factors may also modulate the differentiative potential 
of  this  mesenchymal  lineage.  Such  cell  lines  resemble 
fibroblasts while growing at low density, but, upon reaching 
confluence,  growth ceases and the cells take on the morpho- 
logical and biochemical characteristics  of mature adipocytes 
(Green and Kehinde, 1976). Using adipogenic cell lines, such 
as 3T3-L1, 3T3-F442A, ob17, and 3T3-T, numerous investi- 
gators have shown that the differentiation of these adipoblasts 
can be interfered with by exposure to FGE PDGE or TGF-/3 
(Gaillard etal.,  1984; Hayashi et al., 1981; Ignotz and Mas- 
sagu6, 1985; Sparks and Scott, 1986). Using the C3H-10T1/2 
mouse embryo fibroblast-derived  cell line TA1 (Chapman et 
al.,  1984), we recently demonstrated  that adipogenesis  can 
be prevented by either FGF or the tumor-promoting  phorbol 
ester tetradecanoyl  phorbol-13-acetate  (TPA) as reflected by 
the inability of the cells to undergo morphological  differenti- 
ation or to accumulate  adipocyte-specific  RNAs (Muller et 
al., 1984). The effect of TPA is presumably mediated by acti- 
vation ofPKC (Castagna et al., 1982; Yamanishi et al., 1983) 
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case of myoblasts  treated with FGF, the effects of the growth 
factor or TPA on TA1 cell differentiation  are not due to stimu- 
lation of cell growth (Navre and Ringold,  1988). 
Whereas several studies have reported the ability of growth 
factors to inhibit  adipogenesis only Torti et al. 0985)  have 
demonstrated  reversal  of adipocyte  differentiation  with  a 
peptide  hormone.  In  that  case,  the  macrophage  product 
cachectin,  now known to be tumor necrosis factor  (TNF; 
Beutler et al., 1985), was shown not only to prevent the ac- 
cumulation of adipocyte-specific RNAs in TA1 cells but to 
interfere  with the maintenance of the differentiated  state as 
seen by the coordinate inhibition of adipocyte-specific gene 
expression.  Unfortunately,  little  if  anything  is  currently 
known about the receptor for TNF or the signaling mecha- 
nisms by which it elicits biological responses. 
Here we document that FGF at l0 ng/ml will not only pre- 
vent adipocyte differentiation  but will rapidly reverse the ex- 
pression of adipocyte-specific genes in fully differentiated 
TA1 cells even in adipocytes made PKC deficient by pretreat- 
ment with phorbol esters. In contrast, lower concentrations 
of FGF (1 ng/ml) or the phorbol ester TPA, though capable 
of inducing c-fos  RNA, will block but not reverse adipocyte 
differentiation.  However, TPA in the presence of a calcium 
ionophore  (which  has  no  effect on  its  own)  extinguishes 
adipoycte-specific functions. This finding suggests that there 
are at least two FGF-sensitive pathways  in TA1  cells:  one 
responsible for the initiation of differentiation  (TPA  sensi- 
tive) and another required  for maintenance of the adipose 
phenotype (TPA insensitive).  We surmise that activation  of 
two  classes  of intracellular  messengers-a  PKC-indepen- 
dent, FGF-activated  pathway or a pathway requiring  simul- 
taneous activation of a PKC- and calcium-dependent second 
messenger signaling  systems-are capable of interfering with 
the mechanisms responsible for the maintenance of adipocyte 
differentiation. 
Materials and Methods 
Cell Culture 
TA1  cells (Chapman et al.,  1984)  were grown in Eagle's basal medium 
(Gibco Laboratories, Grand Island, NY) supplemented with 10% FCS (lot 
no. MO131; M. A. Bioproducts, Walkersville,  MD) or, in more recent ex- 
periments, 10% supplemented/defined calf serum (HyClone Laboratories, 
Logan, UT). All serum used was heat inactivated at 55°C for 30 min. Cul- 
tures were grown in 24-well plates or 100-ram dishes at 37°C in a humidified 
incubator at 5% CO2 atmosphere. 
Basic  fibroblast growth  factor was  a  gift of Dr.  D.  Gospodorowicz 
(University of California at San Francisco, San Francisco, CA). All dilu- 
tions of the peptide were made in 1 mg/ml BSA (Sigma Chemical Co., St. 
Louis, MO). EGF was from Collaborative Research (Bedford, MA). The 
phorbel ester TPA was from Sigma Chemical Co., and the calcium iono- 
phore ionomycin was from Calbiochem-Behring Corp. (La Jolla, CA); they 
were each dissolved in DMSO at  1,000x  concentrations so that the final 
DMSO concentration in the culture medium was never >0.2 %. Dexametha- 
sone and indomethacin (Sigma Chemical Co.) were made up at 1,000x con- 
centrations of l  and 30 raM, respectively, in 95 % ethanol. 
RNA Isolation 
Total cellular RNA was isolated using the method of Chirgwin et al. (1979). 
Briefly, after dishes were washed with PBS, 3 ml of lysis buffer (guanidine- 
HCI, pH 5.2, 25 mM sodium citrate, 0.1% N-lauryl sarcosine) was added 
and the suspension was harvested by scraping and transferred to a sterile 
15-ml polypropylene tube (Falcon Labware, Oxnard, CA). The DNA was 
sheared by passing the mixture through a 21-gauge needle 10 times, and 0.5 
vol of absolute ethanol were added. The tubes were placed at -20°C over- 
night and then centrifuged at 7,500 g at 4°C for 20 min to pellet the RNA. 
The RNA pellet was resuspended in 600 pl of lysis buffer and 300 td of 
cold (-20°C) absolute ethanol was added. The tubes were placed at -70°C 
for <1 h and the RNA was recovered by microfitging the pellet for 15 rain. 
The pellet was resuspended in 200/zl of resuspension buffer (I0 mM Tris, 
pH 7.4, 1 mM EDTA, 50 mM NaCI, and 0.2% SDS), the mixture was ex- 
tracted with an equal volume of phenol/chloroform, and the organic phase 
was reextracted once with 100/~1 of water. RNA was precipitated with NaC1 
and ethanol. The RNA pellet was collected and its concentration was deter- 
mined by reading absorbance at 260 nm. 
Analysis of  RNA 
5-10/zg of total RNA was treated with 2.2 M formaldehyde in 50% forma- 
mide, 10 mM NaH2PO4, pH 7, at 55°C for 15 min. Samples were then sub- 
jected to electrophorests in a  1.4%  agarose-formaldehyde gel containing 
2.2  M  formaldehyde, 20 mM morpholine propane sulfonic acid, pH 7, 
5 mM sodium acetate, and I mM EDTA (Lehrach et al., 1977). The gels were 
stained with 10/~g/ml ethidium bromide, and destained with several changes 
of 10 mM NaH2PO4,  pH 7. RNA was then transferred to nitrocellulose or 
Nytran nylon membranes (Schleicher &  Schuell, Inc., Kcene, Nit) using 
20x SSPE (lx  =  0.18 M NaC1,  10 mM NaI-[2PO4, pH 7.7, 1 mM EDTA) 
as previously described (Danielsen et al.,  1986). 
Blots were prehybridized in buffer H (50% formamide, 5x SSPE, 0.1% 
SDS, 2x Denhardt's solution [Ix Denhardt's solution is 0.02%  wt/vol each 
of BSA, polyvinylporrolidone, and Ficoli] 0.5 mg/ml yeast RNA, 0.1 mg/ml 
denatured and sheared salmon sperm DNA) at 42°C for 1 h. Blots were hy- 
bridized in  buffer H  containing radioactive probe for  12-24  h  at 42°C 
(riboprobes at 65°C).  32p-Labeled  probes were made using the random 
hexanuclcotide priming method with the large fragment of DNA polymer- 
ase I (Feinberg and Vogelstein, 1983) or the riboprobe system (Melton et 
al., 1984).  The probe for c-fos used was a gift of Dr. William Lee (Univer- 
sity of  California at San Francisco, San Francisco, CA). It contains a 220-bp 
Ace l-Stu I  fragment derived from the 5' end of exon 4  of the human 
genomic clone (van Straaten et al., 1983) inserted into the riboprobe vector 
sp64 (Promega Biotec, Madison, WI).  The plasmid pmL5, a gift of Dr. 
Todd Kirchgessner (University of California at Los Angeles, Los Angeles, 
CA), was used to detect lipoprotein iipase (LPL) transcripts (Kirchgessner 
et al., 1987). Blots were washed at 50 (for DNA probes) or 65°C (for RNA 
probes) twice for 30 rain in 0.2x SSPE, 0.1% SDS and autoradiographed. 
In all cases, equal amounts or RNA were loaded per lane (based on UV 
absorbance at 260 nm), and this was confirmed by observing equal fluores- 
cence in all lanes of gels stained with ethidium bromide. 
DNA Synthesis Assay 
To determine whether cells were being stimulated to synthesize DNA, the 
method of Hovanessian and Wood 0980) was used to detect the incorpora- 
tion of [3H]thymidine. TA1 cells were seeded in 12- or 24-weU dishes and 
allowed to reach confluence. Control wells were left unfed until the time 
of the experiment. Other wells were refed with media supplemented with 
dexamethasone and indomethacin on days 0 and 3, so that by day 5 they were 
>95 % differentiated. On day 5, control and differentiated cells were treated 
with FGF (10 ng/ml) or left untreated. After 14 h, 0.5 #Ci of [3Hlthymi- 
dine (6.7 Ci/mmol; New England Nuclear) was added per well. 2 h later, 
the medium was removed, cells were washed with PBS, and cold 5% TCA 
was added. The wells were kept at 4°C for 30 rain, then the TCA solution 
was aspirated off, 0.5 ml of  0.1 M NaOH was added, and the dish was main- 
tained at 37°C for 30 min. The base was neutralized with 50 #l of I M HCI, 
and the entire mixture was counted with Aquasol scintillation fluid. 
Results 
Reversal of  Adipocyte Differentiation 
by Various  Agents 
Upon reaching confluence, TA1 adipoblasts slowly differen- 
tiate into mature adipocytes, a process that can be accelerated 
by the addition of different hormones or pharmacological 
agents. Indomethacin, either alone at 125/~M (Knight et al., 
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will cause >95 % of the cells in culture to undergo morpho- 
logical differentiation in 4 d. The differentiation can also be 
documented by the rapid accumulation of adipocyte-specific 
mRNAs,  as  determined  by  RNA  gel-blot  hybridization 
(Northern) analysis (Fig.  1). Markers we have used include 
cDNAs for glycerolphosphate dehydrogenase (Spiegelman et 
al.,  1983);  aP2  (Hunt et al.,  1986;  Chapman et al.,  1984 
[formerly referred to as clone 28 by our group]); two cDNAs 
(clones  1 and 47)  of unknown  function  (Chapman et al., 
1984);  and a  cDNA clone of mouse LPL (Kirchgessner et 
al., 1987). The effects of exogenously added agents on adipo- 
cyte differentiation can be documented using these markers. 
For example, Torti et al. (1985) demonstrated the inhibition 
of glycerolphosphate dehydrogenase, clone 1 and 47 gene ex- 
pression after exposure of TA1  adipocytes to TNE 
We recently reported that addition of 1 ng/ml FGF or 100 
nM  TPA  to  confluent  cultures  of TA1  cells  supplemented 
with  indomethacin blocks differentiation,  as  evidenced by 
the failure of these cells to undergo morphological conver- 
sion or to accumulate clone 1 and aP2 RNAs (Navre and Rin- 
gold,  1988).  We wished to determine whether these same 
factors would reverse adipocyte differentiation as does TNE 
This was accomplished by allowing TA1 cells to differentiate 
completely in the presence of dexamethasone and indometh- 
acin for 5 d. The agents of interest were added on day 5 (5 d 
postconfluence), and RNA was isolated from the cells 18 h 
after treatment.  Our initial studies indicated that these fac- 
tors could not reverse differentiation (not shown). Additional 
experiments, however, showed that FGF is effective if used 
at a concentration of 10 ng/ml (Fig. 1 A, lane 2). TPA, which 
has little or no effect on its own, will extinguish adipocyte- 
specific gene expression if the calcium ionophore ionomycin 
is included simultaneously (lanes 3-5).  Ionomycin also has 
little effect on its own (lane 3). Analogous results have been 
obtained using the calcium ionophore A23187  at identical 
concentrations  (not shown). 
To test whether this inhibition represents a  general phe- 
nomenon attributable to peptide growth factors, we tested the 
effect of EGF or 20 % FCS on these cells. Our results indicate 
that these mitogenic agents do not reduce the levels of the adi- 
pocyte-specific RNAs in differentiated adipocytes (Fig. 1 B). 
FGF at I ng/ml or TPA Are Capable of  Inducing 
c-fos RNA 
The requirement for higher FGF concentrations to reverse 
rather than simply block adipocyte differentiation could be 
due to a  decrease in receptor number in TA1  cells during 
differentiation  or  to  the  activation  of additional  receptor/ 
transduction pathways. Similarly, the inability of TPA to re- 
verse differentiation could be due to down-regulation of PKC 
during adipogenesis. In fact, Stumpo and Blackshear (1986) 
have reported a reduction in PKC activity during the differ- 
entiation of 3T3-L1 adipocytes, although no loss of respon- 
siveness to 160 nM TPA was detected. To begin addressing 
these possibilities, we chose to monitor the well-character- 
ized induction of the protooncogene c-fos by growth factors 
or TPA  (Greenberg and  Ziff,  1984;  Kruijer et  al.,  1984; 
Muller et al.,  1984).  Our initial  studies  (not shown)  indi- 
cated that stimulation of TA1 adipocytes with  100 nM TPA 
resulted in a transient accumulation of c-fos RNA, which was 
Figure 1. Loss of adipocyte-specific RNAs in TA1 cells induced by 
various agents. TAI cells were grown to confluence and differen- 
tiated for 5 d in the presence of dexamethasone and indomethacin. 
The cells, which were refed in the same media on day 3, had gener- 
ally become >95 % fat by day 4. On day 5, the cells were treated 
with the agent(s) indicated and harvested after 18 h.  RNAs from 
each sample were run on a 1.2% agarose gel, transferred to Nytran, 
and probed with 32P-labeled cDNAs corresponding to clones 1 and 
47 and AP2.  (A) Adipoeytes treated  with  (lane NT) control,  no 
treatment; (lane FGFIO) 10 ng/ml FGF; (lane lono) 1/~M ionomy- 
cin; (lane TPA +lono) 100 nM TPA and 1/~M ionomycin; and (lane 
TPA) 100 nM TPA. (B) Adilx~ytes treated with (lane NT) control, 
no treatment; (lane EGF) 100 ng/ml EGF; (lane FGF 10) 10 ng/ml 
FGF;  and (lane 20% b-US) addition of 20%  vol fresh FCS. 
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cytes, as in Fig.  l, were treated with various agents and harvested 
30 min after treatment. RNAs were analyzed as in Fig. 1, but were 
probed with 32p-labeled RNA corresponding  to exon 4 of the hu- 
man c-fos gene. (Lane NT) No treatment; (lane TPA) 100 nM TPA; 
(lanes FGF1 and FGFIO) 1 and 10 ng/ml FGF, respectively; (lane 
lono) 1 #M ionomycin; (lane EGF 10)  10 ng/ml EGF; and (lane 
20% FCS) addition of 20%  vol fresh FCS. 
maximal after 30 min of treatment, consistent with observa- 
tions in other systems. As shown in Fig.  2, both TPA (100 
nM) or low concentrations of FGF (1 ng/ml) are capable of 
inducing  the  accumulation  of c-fos  RNA  in  differentiated 
adipocytes.  Thus,  although  these  factors do  not  affect the 
maintenance of differentiation, at these concentrations they 
are still capable of inducing  cellular responses.  Similarly, 
both FCS  and EGF,  which  also are ineffective as reversal 
agents, induce c-fos RNA. In contrast to its effects on other 
cell types (Moore et al.,  1986; Tsuda et al.,  1986), ionomy- 
cin does not induce any detectable c-fos expression in TA1 
adipocytes.  Of particular  interest,  these  experiments also 
demonstrate that the  repression of adipocyte-specific gene 
expression by 10 ng/ml FGF or TPA plus ionomycin cannot 
be attributed solely to the transient induction of the c-fos gene. 
Requirements for FGF-mediated Reversal 
of Differentiation 
To better characterize the increased requirement for FGF by 
TA1 cells for reversal of differentiation, we investigated the 
levels of FGF required to elicit the reversal of differentiation 
or the inhibition of the onset of differentiation.  Differentia- 
tion reversal was monitored as discussed above. The inhibi- 
tion of differentiation by FGF was accomplished by treating 
adipoblasts with FGF on days 0,  1, and 2 and harvesting on 
day 3 (Navre and Ringold,  1988; Fig. 3). The results of this 
experiment (Fig.  3) show that, whereas inhibition of differen- 
tiation is essentially complete at 3  ng/ml, the reduction of 
adipocyte-specific RNA in fat cells is only minimally effected 
at this concentration,  consistent with our previous findings 
that the inhibition  of differentiation-maintenance functions 
requires higher levels of FGE Although in this figure it ap- 
pears that clone 47 is somewhat more sensitive to FGF than 
aP2 or LPL,  this effect is variable and sometimes LPL is 
more completely inhibited by FGF than is clone 47.  We do 
not know the cause of this  variability, although  it may be 
related to changes in RNA stability. 
In their study of the reversal of BC3H1 myocyte differenti- 
ation, Spizz et al. (1986)  demonstrated that the FGF repres- 
sion of creatine kinase RNA could be blocked by concurrent 
addition of cycloheximide. Likewise, we have found that the 
addition of this protein synthesis inhibitor will block most of 
the growth factor- or TPA plus ionomycin-mediated repres- 
sion of the adipocyte RNAs (Fig. 4). This result suggests that 
the reversal process requires either de novo protein synthesis 
or the activity of a  labile protein. 
FGF Does Not Stimulate Mitogenesis in Adipocytes 
The reduction  of steady-state levels of adipocyte RNAs by 
FGF would be of less interest if it was merely due to the reen- 
try of the aditx~ytes into the cell cycle. To address this issue, 
we  measured  [3H]thymidine  incorporation to test whether 
FGF-treated adipocytes are not stimulated to initiate DNA 
synthesis.  Previous work  showed  that  confluent,  undiffer- 
entiated TA1 cells begin to incorporate  [3H]thymidine  12- 
16 h after serum stimulation (data not shown). In the experi- 
ment shown in Table I, TA1 adipocytes were stimulated with 
20% FCS or 10 ng/ml FGF and labeled with [3H]thymidine 
14 h  later.  As the results indicate,  while the serum causes 
some stimulation of growth,  FGF alone has  no effect.  To 
show that the FGF was functional, we also treated undiffer- 
entiated adipoblasts (also 5 d postconfluence) with FGE Un- 
der these conditions, the adipoblasts do increase their uptake 
of [3H]thymidine (Table I), indicating  that the preparation 
of FGF was active and,  under the  proper conditions,  can 
Figure  3. TAI cell responses to FGE (A) For the reversal of  differen- 
tiation, TAI adipocytes on day 5 were treated with varying concen- 
trations of FGF (0, 1, and 3 ng/ml), harvested after 18 h, and ana- 
lyzed for LPL, clone 47, and aP2 RNA levels as in Fig. 1. (B) For 
the inhibition of  differentiation, TAI adipoblasts on day 0 were refed 
with media supplemented with dexamethasone and indomethacin 
and treated with the indicated concentration of FGF on days 0,  1, 
and 2. Cells were harvested on day 3 and analyzed for LPL, clone 
47, and aP2 RNA levels as above. 
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TAI adiptx~tes on day 5 were treated with 10 ng/ml FGF or TPA 
plus ionomycin as in Fig.  1, but in the presence or absence of 1 
#g/ml cycloheximide. RNAs were harvested as described, and the 
blot was  probed  with 32p-labeled RNAs corresponding to LPL, 
clone 47, and AP2. 
stimulate mitogenesis. The experiment shows, however, that 
the treatment of differentiated adipocytes with high concen- 
trations of FGF is not mitogenic. Similar results have been 
observed up to 20 h  after treatment (data not shown). 
FGF Reversal of Differentiation Is Independent of PKC 
FGF receptor-linked stimulation of PLC, which results in the 
accumulation of diacylglycerol (an activator of PKC) and 
inositol phosphates  (calcium-mobilizing agents),  is one of 
the proposed routes for the generation of FGF receptor-in- 
duced second messengers (Kaibuchi et al.,  1986; Tsuda et 
al., 1985). The finding that TPA plus ionomycin, but neither 
alone, can effect reversal of adipocyte differentiation, sug- 
gests that  PLC activation might be the mediator of FGF- 
Table L  Effect of FGF on [3H]Thymidine Incorporation in 
TA1 Fibroblasts and Adipocytes 
[3H]Thymidine  incorporation* 
Cell type  No addition  With FGF  With FCS 
Adipocyte~:  0.97  0.46  5.8 
Adipoblast§  3.2  20  ND 
* Incorporation  into cells measured in cpm (× 10-3), over a 2-h  period,  14 h 
after addition of FGF. 
¢ Cells were seeded on day -5 and refed with media supplemented  with dex- 
amethasone and indomethacin on days 0 and 3, so that by day 5 they were >95 % 
differentiated. 
§ Cells were seeded on day -5 and left unfed until the time of the experiment 
(day + 5). Less than 10% of these cells show the morphology of differentiated 
adipoblasts. 
stimulated  reversal.  To test this hypothesis,  we pretreated 
adipocytes on day 4  with a very high concentration of TPA 
(10/zM), which has been shown to cause a depletion of PKC 
in  3T3-L1 adipocytes (Stumpo and Blackshear,  1986).  To 
confirm that the TA1 adipocytes treated in this manner are 
no longer capable of undergoing a PKC-mediated response, 
100 mM TPA was added 18 h after pretreatment and the cells 
were harvested after 30 min to assay for c-fos induction. As 
shown in Fig. 2 A and Fig. 4 A, adipocytes exhibit a vigorous 
induction of c-fos RNA in response to FGF or TPA. In con- 
trast, cells pretreated with 10 #M TPA for 18 h have no re- 
sponse at all to TPA, yet maintain a near-maximal response 
to  FGF  (Fig.  5  A).  This demonstrates  (a)  that  the  PKC- 
mediated response is greatly attenuated in the cells pretreated 
with 10/zM TPA; and (b) that FGF is capable of inducing 
c-fos  through PKC-independent pathways. 
To determine whether PKC  activity is  required for the 
FGF-mediated loss of adipocyte-specific RNAs, control and 
TPA-pretreated cells were challenged with FGF or with TPA 
plus ionomycin as above. As shown in Fig. 5 B, pretreatment 
with TPA has little effect on FGF reversal of differentiation, 
whereas the reversal induced by TPA plus ionomycin is virtu- 
ally eliminated by PKC down-regulation. Similar results (not 
shown) were obtained even when we did not add the very 
small (100 nM) dose of TPA at 18 h, indicating that the initial 
10 #M TPA pretreatment was capable of repressing PKC lev- 
els throughout the 36 h of the experiment. 
Discussion 
Many recent studies have clearly demonstrated that peptide 
growth factors can have effects on cellular metabolism that 
are not directly related to proliferation (Sporn and Roberts, 
1988). One aspect of these effects that has received a modi- 
cum of  attention is the inhibition by these factors of myogenic 
and adipogenic differentiation. In nearly all cases, the inves- 
tigations have focused on the ability of the factor in question 
to block the conversion of the determined stem cell to its ma- 
ture phenotype. In only two cases have the effects of growth 
factors on already differentiated cells been tested. The best 
series of studies have been those using the BC3H1 cell line, 
which loses its muscle-specific markers in the presence of 
purified FGE Lathrop et al.  (1985a,b) have clearly shown 
that these cells extinguish myogenic gene expression without 
reentering the cell cycle, suggesting that FGF is capable of 
moving differentiated cells into an uncharacterized compart- 
ment of the G1 portion of the cell cycle in which differen- 
tiated functions cannot be expressed. Similarly, Torti et al. 
(1985)  reversed the differentiation of TA1  adipocytes with 
TNF/cachectin, which causes the cells to lose their adipose 
phenotype, also without reentering the cell cycle. 
The goal of the current work has been to further character- 
ize the ability of growth factors to reverse adipocyte differen- 
tiation.  We are  especially interested  in  understanding  the 
nature  of the  physiologically relevant second  messengers 
generated by these peptide hormones and determining the 
mechanisms by which they affect the expression of differen- 
tiation-specific genes. Our previous work showed that either 
FGF or TPA treatment would block the differentiation of TA1 
adipoblasts (Navre and Ringold, 1988), suggesting that acti- 
vation of the PKC pathway alone is sufficient to block the 
conversion.  In  contrast,  treatment  of  fully  differentiated 
Navre and Ringold Growth Factor Reversal of Adipocyte Differentiation  1861 Figure 5.  Effects  of down-regulation of PKC. TA1 adipocytes on 
day 4 were either left untreated or were pretreated with 10 #M TPA. 
On day 5,  18 h after pretreatment, the cells were then challenged 
with: (lane NT) no challenge; (lanes FGF 10 and FGF) 10 and 1 ng/ 
ml FGF, respectively, for A and B, respectively; and (lanes TPA and 
TPA + ION) 100 nM TPA and 100 nM TPA plus 1 #M ionomycin, 
respectively, for A and B, respectively. Cells were then harvested 
after 30 min (A) or 18 h (B). RNA blots were probed with c-fos 
(A) as in Fig. 2 or LPL, clone 47, and AP2 (B) as in Fig. 3. 
adipocytes with identical levels of these agents had no effect 
on the expression of adipocyte-specific RNAs. This suggests 
that once the triggering of adipocyte differentiation has oc- 
curred (an event sensitive to the presence of FGF at 1 ng/ml 
or TPA), mechanisms required for the maintenance of the 
adipose phenotype begin to function; these mechanisms are 
refractory to FGF (at  1 ng/ml) or TPA treatment. We have 
found that the failure of these agents to inhibit the main- 
tenance pathway is not due to the inability of adipocytes to 
respond to them, as demonstrated by the induction c-fos RNA 
expression by both FGF (at 1 ng/ml) and TPA (Fig. 2). 
Additional  studies  demonstrated  that  the  maintenance 
pathway can be rendered sensitive to FGF or TPA under cer- 
tain conditions. Specifically, we found that using higher con- 
centrations of FGF (>t10 ng/ml) or treatment with TPA con- 
currently  with  a  calcium  ionophore  (which  is  ineffective 
when used on its own; Fig.  1) will potently inhibit the func- 
tion of the maintenance pathway(s). These results suggest a 
model in which one or more substrates must be acted upon 
to shut down adipocyte-specific gene expression. 
The ability of the combined actions of the PKC and cal- 
cium pathways to suppress differentiation-specific functions 
suggests  that  hormones  that  activate  these  pathways,  for 
example,  by stimulation of a  phosphatidylinositol-specific 
PLC, should have similar effects. Since FGF (at 10 ng/ml) 
is capable of inhibiting adipocyte-specific gene expression it 
seemed prudent to determine whether FGF was,  in  fact, 
operating via such a pathway. We therefore tested whether or 
not the activation of PKC was required. Not surprisingly, we 
found that PKC down-regulation blocked the effect of TPA 
plus ionomycin. The loss of PKC activity, however, had little, 
if any, effect on the ability of FGF to reduce the expression 
of the RNAs tested. This result strongly suggests that FGF 
elicits its effect on adipocyte-specific genes through a PKC- 
independent pathway, and that it is unlikely that activation of 
a classical PKC plays a role in mediating the FGF-induced 
reversal of differentiation. One must conclude that the ac- 
tion(s) of other, as yet uncharacterized, signal transduction 
pathways are involved, and that, in TA1 adipocytes, they are 
not activated until FGF concentrations reach 10 ng/ml. It is 
important to note, however, that PKC-independent FGF path- 
ways must also be functional at 1 ng/ml FGF since c-fos RNA 
is inducible by the growth factor at this concentration in PKC- 
deficient cells (data not shown). 
Our studies clearly show that two classes of signal trans- 
duction  pathways-one  induced  by  concurrent PKC  and 
Ca  2+ activation and  a  second induced by FGF in a  PKC- 
independent manner- can inhibit the maintenance of adipo- 
cyte-specific gene expression.  FGF may be functioning in 
BC3H1 myocytes as it does in TA1 adipocytes given that the 
effect in both cell types is blocked by cycloheximide (Spizz 
et al.,  1986) and that in neither is the reversal of differentia- 
tion  dependent on mitogenic stimulation  (Lathrop et al., 
1985a,b;  Spizz et al.,  1986). The results obtained here do 
not reveal, however, whether the effects of  FGF and TPA plus 
ionomycin are directly on adipocyte gene transcription or on 
mRNA stability.  We are currently beginning experiments to 
address this issue, including nuclear run-on assays and heter- 
ologous gene fusions to delineate the mechanism(s) of the in- 
hibition. Elucidation of the signal transduction pathways ac- 
tivated by FGF in these experimental paradigms may shed 
light on the biochemical processes involved in maintaining 
the differentiated state. 
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